CorMedix Inc CRMD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:55 PM EST
7.05quote price arrow down-0.32 (-4.34%)
Volume
477,360
52 week range
2.16 - 18.80

...

Loading . . .

KEY STATS

  • Open7.35
  • Day High7.35
  • Day Low6.85
  • Prev Close7.37
  • 52 Week High18.80
  • 52 Week High Date02/19/21
  • 52 Week Low2.16
  • 52 Week Low Date03/19/20
  • Market Cap226.52M
  • Shares Out32.13M
  • 10 Day Average Volume2.72M
  • Dividend-
  • Dividend Yield-
  • Beta2.61
  • 1 Year % Change20.93

RATIOS/PROFITABILITY

  • EPS (TTM)-0.78
  • P/E (TTM)-8.99
  • Fwd P/E (NTM)-7.70
  • EBITDA (MRQ)-26.448M
  • ROE (MRQ)-67.26%
  • Revenue (MRQ)210,000.00
  • Gross Margin (MRQ)6.99%
  • Net Margin (MRQ)-10,199.69%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/17/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest CorMedix Inc News

There is no recent news for this security.

Latest CRMD News From Our Partners

QUOTE FINDER

Profile

MORE
CorMedix Inc. is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company has in-licensed the rights to develop and commercialize its product candidate, CRMD003 (Neutrolin), which addresses market opportunities in the instances in which a central venous catheter is used, such as hemodialysis, intensive...
Myron Kaplan J.D.
Chairman
Khoso Baluch
Chief Executive Officer
Matthew David M.D.
Chief Financial Officer
Phoebe Mounts Ph.D.
Executive Vice President
John Armstrong
Executive Vice President
Address
300 CONNELL DRIVE, SUITE 4200
Berkeley Heights, NJ
07922
United States